ORKA Q3 2020 Earnings — Oruka Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ORKAOruka Therapeutics, Inc.

$1B

Q3 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$26,000

Operating Income

-$2M

Net Income

-$2M

EPS (Diluted)

$-3.95

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$52M

Total Liabilities

$2M

Stockholders' Equity

$50M

Cash & Equivalents

$51M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$26,000	-$22,000	-18.2%
Operating Income	-$2M	-$1M	-59.6%
Net Income	-$2M	-$1M	-72.2%